05 Apr 2022

Anna Wu, PhD to present, "CD8 ImmunoPET using Zr89crefmirlimab for Imaging Responses to Immunotherapy" at the Tucson Symposium on April 5th

ImaginAb’s Founder and Chief Scientific Advisor, Anna Wu, PhD, will present,
“CD8 ImmunoPET using Zr-89crefmirlimab for Imaging Responses to Immunotherapy” at the Tucson Symposium 2022, "Innovations in Cancer Science and Diagnostics" virtual event on April 5th at 10am (PST).

This event will be held April 4th – 6th and registration is now open until March 25th.

If you want to know more about ImaginAb and our vision or if you’re interested in learning more about our technologies, then visit imaginab.com or contact us at [email protected]

Click here for more information and to register.